Page last updated: 2024-08-17

pilocarpine and cysteamine

pilocarpine has been researched along with cysteamine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ghigo, E; Locatelli, V; Massare, F; Müller, EE; Redaelli, M; Torsello, A1
Camanni, F; Caroleo, MC; Cermenati, P; Ghigo, E; Locatelli, V; Müller, EE; Panzeri, G; Torsello, A1
Maeda, N; Matsuoka, N; Yamaguchi, I; Yamazaki, M1
BONNETTE, GH; HAYWARD, JR; KIELTS, TR1

Reviews

1 review(s) available for pilocarpine and cysteamine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for pilocarpine and cysteamine

ArticleYear
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin.
    The Journal of endocrinology, 1986, Volume: 111, Issue:2

    Topics: Afferent Pathways; Animals; Atropine; Cysteamine; Growth Hormone; Growth Hormone-Releasing Hormone; Hypothalamus; Hypothalamus, Middle; In Vitro Techniques; Male; Parasympatholytics; Parasympathomimetics; Pilocarpine; Pirenzepine; Rats; Rats, Inbred Strains; Somatostatin

1986
Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat.
    The Journal of endocrinology, 1988, Volume: 117, Issue:2

    Topics: Animals; Atropine; Cysteamine; Feedback; Growth Hormone; Hypothalamus; Male; Pilocarpine; Rats; Rats, Inbred Strains; Somatostatin

1988
Brain somatostatin depletion by cysteamine attenuates the penile erection induced by serotonergic and dopaminergic, but not by cholinergic, activation in rats.
    Brain research, 1996, Aug-05, Volume: 729, Issue:1

    Topics: Animals; Apomorphine; Brain; Cysteamine; Dopamine Agonists; Fenfluramine; Male; Muscarinic Agonists; Penile Erection; Pilocarpine; Rats; Rats, Inbred F344; Serotonin Agents; Somatostatin

1996
HISTOLOGIC AND PHYSIOLOGIC ALTERATIONS IN THE CANINE PAROTID GLAND FOLLOWING THE PREIRRADIATION RETROGRADE INSTILLATION OF 2-MERCAPTO-ETHYLAMINE (CYSTEAMINE).
    Oral surgery, oral medicine, and oral pathology, 1964, Volume: 18

    Topics: Animals; Cysteamine; Dogs; Ethylamines; Parotid Gland; Pathology; Pharmacology; Pilocarpine; Radiation Effects; Research

1964